TotalMarketCap

Humacyte

HUMANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$108.341 M

$0.39 -13.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Humacyte (HUMA) has a market capitalization of $108.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.04M

#3393 by revenue

Earnings

-$40.8M

Loss-making

Shares outstanding

277,798,105

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #107Cardiol TherapeuticsCRDL$112.1M
  2. #108Armata PharmaceuticalsARMP$111.2M
  3. #109HumacyteHUMA$108.3M
  4. #110Outlook TherapeuticsOTLK$107.3M
  5. #111Voyager TherapeuticsVYGR$106.0M

What if Humacyte were worth as much as…

Open the what-if tool →

Gold $28.2T

$101,645.31

Per share 260,629× higher

Bitcoin $1.53T

$5,499.85

Per share 14,102× higher

Apple $5.02T

$18,055.50

Per share 46,296× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Humacyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.